Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice (Q46640341)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2005

Language	Label	Description	Also known as
English	Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice	scientific article published in August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

0 references

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

object named as

John McMurray

1

0 references

Alain Cohen-Solal

2

object named as

Alain Cohen-Solal

1 reference

Europe PubMed Central

23 December 2017

12

object named as

Karl Swedberg

1 reference

Europe PubMed Central

23 December 2017

7

object named as

Henry Krum

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Aldo P. Maggioni

8

object named as

Aldo Maggioni

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

10

object named as

Ileana L Piña

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Robert S McKelvie

9

object named as

Robert S McKelvie

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

author name string

Rainer Dietz

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Eric Eichhorn

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Leif Erhardt

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Jordi Soler-Soler

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

publication date

1 August 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

European Journal of Heart Failure

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

710-721

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

Why we must teach evidence-based medicine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

[Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology--Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceut

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Underutilisation of ACE inhibitors in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Undertreatment of congestive heart failure in an Australian setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Austrian survey of treating heart failure--AUSTRIA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Treatment of heart failure with spironolactone--trial and tribulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Tolerability of spironolactone in patients with chronic heart failure -- a cautionary message

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

How much responsibility should heart failure nurses take?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds—the TEMISTOCLE study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Improving Guideline Adherence

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.002

21 January 2018

Identifiers

10.1016/J.EJHEART.2005.07.002

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16087129

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46640341&oldid=2123656538"